切换至 "中华医学电子期刊资源库"

中华消化病与影像杂志(电子版) ›› 2021, Vol. 11 ›› Issue (05) : 193 -195. doi: 10.3877/cma.j.issn.2095-2015.2021.05.001

临床研究

上海市嘉定区炎症性肠病患者的粪便钙卫蛋白检测研究
杨翠萍1, 全旭1, 孙顺昌1, 张梦茵1, 张金叶1, 贾颖1, 俞骁珺1, 谢玲1, 蔡波尔1, 吴云林1, 陈平1,()   
  1. 1. 201801 上海交通大学医学院附属瑞金医院消化内科
  • 收稿日期:2021-02-11 出版日期:2021-10-01
  • 通信作者: 陈平

Study of fecal calprotectin detection in patients with inflammatory bowel disease in Jiading district of Shanghai of China

Cuiping Yang1, Xu Quan1, Shunchang Sun1, Mengyin Zhang1, Jinye Zhang1, Ying Jia1, Xiaojun Yu1, Ling Xie1, Bo′er Cai1, Yunlin Wu1, Ping Chen1,()   

  1. 1. Department of Gastroenterology, Ruijin Hospital of School of Medicine of Shanghai Jiaotong University, Shanghai 201801, China
  • Received:2021-02-11 Published:2021-10-01
  • Corresponding author: Ping Chen
引用本文:

杨翠萍, 全旭, 孙顺昌, 张梦茵, 张金叶, 贾颖, 俞骁珺, 谢玲, 蔡波尔, 吴云林, 陈平. 上海市嘉定区炎症性肠病患者的粪便钙卫蛋白检测研究[J/OL]. 中华消化病与影像杂志(电子版), 2021, 11(05): 193-195.

Cuiping Yang, Xu Quan, Shunchang Sun, Mengyin Zhang, Jinye Zhang, Ying Jia, Xiaojun Yu, Ling Xie, Bo′er Cai, Yunlin Wu, Ping Chen. Study of fecal calprotectin detection in patients with inflammatory bowel disease in Jiading district of Shanghai of China[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2021, 11(05): 193-195.

目的

探讨粪便钙卫蛋白(FC)在上海市嘉定地区炎症性肠病患者临床诊断中的意义。

方法

选取2020年3月至2020年5月上海瑞金医院北部院区43例研究对象的粪便样本,分成2组,炎症性肠病(IBD)组28例和健康对照组15例。采用荧光免疫层析法定量检测粪便中FC浓度。

结果

15例健康者FC浓度为(40.63)μg /g,28例IBD患者平均为(323.45)μg /g。IBD患者与健康者FC浓度比较有显著差别(P<0.05)。以60 μg /g为临界值时,FC判断IBD是否活动的灵敏度和特异度分别为82.14%和86.67%,活动期IBD患者与静止期IBD患者和健康者FC浓度比较均也有显著差异(P<0.05)。

结论

FC检测作为一种非侵入性诊疗方法,可作为内镜下诊断疾病活动性的一种替代指标,在上海嘉定地区诊断IBD以及评估疾病活动性具有良好的应用价值。

Objective

To investigate the value of fecal calprotectin(FC)in the diagnosis of patients with inflammatory bowel disease(IBD)in Jiading district of Shanghai of China.

Methods

The fecal samples of 43 subjects from March 2020 to May 2020 in North District of Shanghai Ruijin Hospital were collected and divided into two groups: IBD group(n=28)and healthy control group(n=15). Fluorescence immunochromatography was used to quantitatively detect FC concentration in feces.

Results

The FC concentration in 15 healthy subjects was 40.63 μg/g, and that in 28 patients with was 323.45 μg/g.There was a significant difference in FC concentration between IBD group and control group(P<0.05). When 60 μg/g was taken as the critical value, the sensitivity and specificity of FC to determine whether IBD was active or not were 82.14% and 86.67%, respectively.There were also significant differences in FC concentrations between active IBD patients and inactive IBD patients and healthy subjects(P<0.05).

Conclusion

FC test, as a non-invasive diagnosis and treatment method, can be used as an alternative index for endoscopic diagnosis of disease activity, which has a good application value in the diagnosis of IBD and the assessment of disease activity in Jiading district of Shanghai of China.

表1 炎症性肠病患者与健康者粪便钙卫蛋白浓度比较(μg/g)
表2 活动期和静止期炎症性肠病患者的粪便钙卫蛋白浓度比较(μg/g)
1
中华医学会消化病学分会炎症性肠病协作组.中国炎症性肠病诊断治疗规范的共识意见[J].中华内科杂志,2008,47(1):73-79.
2
Flynn S, Eisenstein S.Inflammatory Bowel Disease Presentation and Diagnosis[J].Surg Clin North Am,2019,99(6):1051-1062.
3
Echarri Piudo A.Inflammatory bowel disease - Newer models of care[J].Rev Esp Enferm Dig,2019,111(8):577-578.
4
Hanić M, Trbojević-AkmaičIć, Lauc G.Inflammatory bowel disease-glycomics perspective[J].Biochim Biophys Acta Gen Subj,2019,1863(10):1595-1601.
5
Pisani LF, Moriggi M, Gelfi C,et al.Proteomic insights on the metabolism in inflammatory bowel disease[J].World J Gastroenterol,2020,26(7):696-705.
6
Johne B, Fagerhol M K, Lybrg T,et al.Functional and cEnical aspects of the myelomonocyte protein calprotectin[J].J Clin Path-Mol Path,1997,50(3):113-123.
7
Gebhardt C, Nemeth J, Angel P,et al.S100A8 and S100A9 in inflammation and cancer[J].Biochemical Pharmacology,2006,72(11):1622-1631.
8
Roseth AG, Schmidt PN, Fagerhol MK.Correlation between faecal excretion of indium-111 -labelled granulocytes and calprotectin,a granulocyte maricer protein,in patients with inflammatory bowel disease[J].Scand J Gagtroentero,1999,34(1):50-54.
9
Sander J, Fagerlol MK, Bakkon JS,et al.Plasma levels of the leukocyte LI protein in febrile conditions:relation to aetilolgy t number of leucocytes in blood,blood sedimentation reaction and C-reaction protein[J].Scand J Clin Lav Invest,1984,44(4):357-362.
10
Ayling RM, Kok K.Fecal Calprotectin[J].Adv Clin Chem,2018,87:161-190.
11
Ricciuto A, Griffiths AM.Clinical value of fecal calprotectin[J].Crit Rev Clin Lab Sci,2019,56(5):307-320.
12
Vernia F, Di Ruscio M, Stefanelli G,et al.Is fecal calprotectin an accurate marker in the management of Crohn′s disease?[J].J Gastroenterol Hepatol,2020,35(3):390-400.
13
20 Caviglia GP, Ribaldone DG, Rosso C,et al.Fecal calprotectin:beyond intestinal organic diseases[J].Panminerva Med,2018,60(1):29-34.
14
Mumolo MG, Bertani L, Ceccarelli L,et al.From bench to bedside:Fecal calprotectin in inflammatory bowel diseases clinical setting[J].World J Gastroenterol,2018,24(33):3681-3694.
15
Mosli MH, Zou G, Garg SK,et al.C-Reactive Protein,Fecal Calprotectin,and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients:A Systematic Review and Meta-Analysis[J].Am J Gastroenterol,2015,110(6):802-819;quiz 820.
16
Sharbatdaran M, Holaku A, Kashifard M,et al.Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon:a study in Babol,Northern,Iran[J].Caspian J Intern Med,2018,9(1):60-64.
17
Sands BE.Biomarkers of Inflammation in Inflammatory Bowel Disease[J].Gastroenterology,2015,149(5):1275-1285.
18
Roseth A G, Fageriiol M K, Aadland E.Assessment of the neutrophil dominating protein calprotectin in feces,a methodogic study[J].Scand J Gastroenterol,1992,27(9):793-798.
19
Inch R D, Pont E D, Leo V D,et al.Calprotectin and lactoferrin in the assessmen of intestinal inflammation and organic disease[J].Int J Colorectal Dis,2007,22(4)429-437.
20
Schoepfer A M, Trummler M, Seeholzer P,et al.Accuracy of four fecal assays in the diagnosis of colitis[J].Dis Colon Rectum,2007,50(10):1697-1706.
21
Younes C.Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak[J].Dig Liver Dis,2020,52(11):1230.
22
Menees SB, Powell C, Kurlander J,et al.A meta-analysis of the utility of C-reactive protein,erythrocyte sedimentation rate,fecal calprotectin,and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS[J].Am J Gastroenterol,2015,110(3):444-454.
23
Klingberg E, Magnusson MK, Strid H,et al.A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin[J].Arthritis Res Ther,2019,21(1):248.
24
Bertani L, Mumolo MG, Tapete G,et al.Fecal calprotectin:current and future perspectives for inflammatory bowel disease treatment[J].Eur J Gastroenterol Hepatol,2020,32(9):1091-1098.
[1] 郭伟仪, 林沛玲. 不同抗体型幽门螺杆菌感染与溃疡性结肠炎患者疾病活动及组织学评分的关系[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 237-244.
[2] 丁召, 李翊, 徐天天. 开腹探查+回盲部切除+小肠结肠吻合术[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 281-281.
[3] 董晓斌, 张静, 苏莎莎, 莎比亚·沙吾提, 盛好. 溃疡性结肠炎患者相关环状RNA 差异表达谱分析及功能研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 499-509.
[4] 陈利, 杨长青, 朱风尚. 重视炎症性肠病和代谢相关脂肪性肝病间的串话机制研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 385-389.
[5] 陈憩, 顾于蓓. 不同亚型上消化道克罗恩病的临床特点和预后差异研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 121-127.
[6] 吕涛, 张琨, 李晨. 芍黄安肠汤治疗重度活动期溃疡性结肠炎大肠湿热证患者的疗效及对肠黏膜屏障、炎症因子和免疫功能的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 16-20.
[7] 刘萍, 刘占举, 张萃. 英夫利西单抗治疗克罗恩病的临床疗效及影响因素[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 28-34.
[8] 朱琴琴, 慈娟娟, 崔璐, 许海蓉, 李宇新, 丁炎波. 凝血功能、血脂、C反应蛋白及中性粒细胞/淋巴细胞水平对克罗恩病活动性评估及临床诊断的价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 35-40.
[9] 陈娟, 胡晓华, 李洪梅, 王志军. CT小肠造影对克罗恩病的诊断评估价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 41-44.
[10] 蒋心怡, 顾丹丹, 叶艳, 缪佳蓉. RNA测序研究抗菌肽KT2治疗溃疡性结肠炎的作用机制[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(01): 8-15.
[11] 王秀, 王义国. 乌司奴单抗治疗克罗恩病肛周瘘管的有效性和安全性分析[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(06): 514-519.
[12] 屈霄, 王靓, 陆萍, 何斌, 孙敏. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J/OL]. 中华消化病与影像杂志(电子版), 2023, 13(06): 466-470.
[13] 乔晓红, 薛晓峰, 查振刚, 蔡若莲, 牛建军, 任立新, 杨慧峰, 李雪梅, 郭秀珍. 骨关节炎患者血清中Vaspin的表达及其与关节病变严重程度的关系[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 152-158.
[14] 王卫峰, 刘维薇. 血清胰蛋白酶2在克罗恩病炎症程度评估中的价值[J/OL]. 中华临床医师杂志(电子版), 2023, 17(12): 1304-1308.
[15] 黄锦, 温静, 李佳霖, 韩丹, 刘翠华, 杨殿辉, 张洋洋. 双联抗血小板药物对溃疡性结肠炎患者的影响及处理策略[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(03): 195-199.
阅读次数
全文


摘要